Lower Energy Consumption Icon
Optimized bioreactor design reduces the need for high-power mechanical agitation, lowering operational cost. [Image of Cost Reduction Icon]
Xanthan Gum is a high-demand polysaccharide widely used as a Thickeners/EOR Enhanced Oil Recovery agent in food, pharmaceuticals, and industrial applications due to its exceptional viscosity and stability. The traditional fermentation process faces key difficulties: High viscosity limits oxygen transfer and increases mixing energy required in the bioreactor, and the native inconsistent quality of Xanthomonas campestris fermentation leads to variable product performance.
CD Biosynsis offers a two-pronged solution focusing on both strain performance and process engineering: Genetic Modification: Modify the Gum gene cluster to control the structure of the pentasaccharide repeating unit, tailoring the viscosity profile. This allows for customized viscosity properties. Simultaneously, we implement Bioreactor Optimization: Implement non-conventional bioreactors e.g., bubble column optimized for high-viscosity broth. This overcomes the critical mass and oxygen transfer limitations posed by the high-viscosity fermentation environment, ensuring high yield and reduced operational cost.
Get a QuoteThe industrial production of Xanthan Gum faces these primary challenges:
An effective solution must simultaneously address the biological limitations of the strain and the mass transfer constraints of the bioreactor.
CD Biosynsis utilizes integrated strain and process engineering to optimize Xanthan Gum production:
Tailored Viscosity Profile
We genetically modify the Gum gene cluster that controls Xanthan Gum synthesis, allowing for precise control over the pentasaccharide structure and thus the final viscosity and rheological properties.
Bioreactor Mass Transfer Optimization
We implement and optimize non-conventional bioreactors e.g. airlift or bubble column, which offer high oxygen transfer and low shear stress suitable for Xanthan Gum's high-viscosity broth.
Stress and OTR Tolerance
We engineer the Xanthomonas campestris host for enhanced stress tolerance e.g. shear stress and improved intrinsic oxygen uptake rate, boosting performance under challenging fermentation conditions.
Genetic Stability Assurance
We utilize chromosomal integration techniques for the Gum cluster modifications, ensuring the long-term genetic stability of the high-performance strain and consistent product quality. [Image of High Conversion Efficiency Icon]
This comprehensive approach overcomes the major yield and quality constraints of Xanthan Gum biomanufacturing.
Our Xanthan Gum engineering service is dedicated to pursuing the following production goals:
Lower Energy Consumption Icon
Optimized bioreactor design reduces the need for high-power mechanical agitation, lowering operational cost. [Image of Cost Reduction Icon]
Customized Product Performance Icon
Targeted Gum cluster modification allows for precise tuning of viscosity for specific applications e.g. EOR vs food.
Increased Final Titer Icon
Improved OTR and strain robustness lead to significantly higher Xanthan Gum concentration in the final broth.
Consistent Quality Icon
Genetically stable strains ensure batch-to-batch consistency in molecular weight and rheological behavior.
Enhanced Bioreactor Performance Icon
Use of non-conventional designs is optimized for the unique rheological demands of Xanthan Gum fermentation.
We deliver an economically and rheologically superior platform for Xanthan Gum biomanufacturing.
Our Xanthan Gum engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-performance, cost-efficient Xanthan Gum supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is oxygen transfer the major bottleneck in Xanthan Gum production?
Xanthan Gum fermentation uses the aerobic bacterium Xanthomonas campestris. As the gum is produced, the fermentation broth becomes extremely viscous, up to $10^{5 cP, which severely hinders the dispersion of oxygen bubbles and reduces the oxygen transfer rate (k}_{\text{L}}\text{a). This oxygen limitation starves the cells, directly limiting the final Xanthan Gum titer and productivity.
How does modifying the Gum cluster tailor the viscosity?
The Gum gene cluster controls the synthesis and modification of the Xanthan Gum pentasaccharide repeating unit. By modifying genes that control the acetylation and pyruvylation levels, we can subtly change the molecular structure. This structural change directly influences the gum's stiffness and interactions, allowing for a customized viscosity profile to meet specific client needs.
Why use non-conventional bioreactors?
Conventional stirred-tank reactors require excessive power to mix highly viscous fluids, leading to high energy costs and potential shear stress damage to the cells. Non-conventional designs e.g. bubble columns or airlift reactors rely on pneumatic mixing. They offer a much higher oxygen transfer rate per unit power input and lower shear stress, making them more cost-effective and biologically friendly for Xanthan Gum production.
How is product quality consistency ensured?
Inconsistent quality is often a result of genetic instability in the host. We address this by using stable chromosomal integration for all genetic modifications, eliminating the use of unstable plasmids. This ensures that every cell in the fermentation culture maintains the same engineered Gum gene cluster, guaranteeing consistent molecular weight and rheological properties batch after batch.
What is the estimated project timeline?
A comprehensive project involving Gum cluster engineering, strain robustness, and bioreactor optimization typically requires 32-42 weeks for final strain delivery and validated industrial-scale process protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.